Neuronetics, Inc. (STIM) stock
STIMNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$1.39−0.04 (-2.80%)
Close on Nov 13, 2026Market cap $105.91MP/E –Yield –
Neuronetics ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Neuronetics's ebitda for the twelve months ending Sep 30, 2026 was -$12.79M. For fiscal 2025 it was -$27.97M. The highest annual figure on record is -$8.66M in fiscal 2016.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$27.97M | – |
| FY2024 | Dec 31, 2024 | -$32.49M | – |
| FY2023 | Dec 31, 2023 | -$28.55M | – |
| FY2022 | Dec 31, 2022 | -$33.46M | – |
| FY2021 | Dec 31, 2021 | -$26.50M | – |
| FY2020 | Dec 31, 2020 | -$21.37M | – |
| FY2019 | Dec 31, 2019 | -$25.87M | – |
| FY2018 | Dec 31, 2018 | -$18.95M | – |
| FY2017 | Dec 31, 2017 | -$13.01M | – |
| FY2016 | Dec 31, 2016 | -$8.66M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $841.00K | – |
| Q2 FY2026 | Jun 30, 2026 | -$1.10M | – |
| Q1 FY2026 | Mar 31, 2026 | -$8.25M | – |
| Q4 FY2025 | Dec 31, 2025 | -$4.28M | – |
| Q3 FY2025 | Sep 30, 2025 | -$6.82M | – |
| Q2 FY2025 | Jun 30, 2025 | -$7.56M | – |
| Q1 FY2025 | Mar 31, 2025 | -$10.10M | – |
| Q4 FY2024 | Dec 31, 2024 | -$11.03M | – |
| Q3 FY2024 | Sep 30, 2024 | -$7.23M | – |
| Q2 FY2024 | Jun 30, 2024 | -$7.91M | – |
| Q1 FY2024 | Mar 31, 2024 | -$6.30M | – |
| Q4 FY2023 | Dec 31, 2023 | -$3.92M | – |
| Q3 FY2023 | Sep 30, 2023 | -$8.37M | – |
| Q2 FY2023 | Jun 30, 2023 | -$6.85M | – |
| Q1 FY2023 | Mar 31, 2023 | -$9.39M | – |
| Q4 FY2022 | Dec 31, 2022 | -$7.12M | – |
| Q3 FY2022 | Sep 30, 2022 | -$7.05M | – |
| Q2 FY2022 | Jun 30, 2022 | -$9.50M | – |
| Q1 FY2022 | Mar 31, 2022 | -$9.82M | – |
| Q4 FY2021 | Dec 31, 2021 | -$6.62M | – |
| Q3 FY2021 | Sep 30, 2021 | -$6.98M | – |
| Q2 FY2021 | Jun 30, 2021 | -$6.26M | – |
| Q1 FY2021 | Mar 31, 2021 | -$6.63M | – |
| Q4 FY2020 | Dec 31, 2020 | -$2.46M | – |
| Q3 FY2020 | Sep 30, 2020 | -$2.22M | – |
| Q2 FY2020 | Jun 30, 2020 | -$6.66M | – |
| Q1 FY2020 | Mar 31, 2020 | -$10.07M | – |
| Q4 FY2019 | Dec 31, 2019 | -$6.64M | – |
| Q3 FY2019 | Sep 30, 2019 | -$6.03M | – |
| Q2 FY2019 | Jun 30, 2019 | -$6.31M | – |
| Q1 FY2019 | Mar 31, 2019 | -$6.85M | – |
| Q4 FY2018 | Dec 31, 2018 | -$5.45M | – |
| Q3 FY2018 | Sep 30, 2018 | -$4.13M | – |
| Q2 FY2018 | Jun 30, 2018 | -$4.94M | – |
| Q1 FY2018 | Mar 31, 2018 | -$4.47M | – |
| Q4 FY2017 | Dec 31, 2017 | -$4.09M | – |
| Q3 FY2017 | Sep 30, 2017 | -$2.71M | – |
See a number that looks wrong?